What is NDC 65862-249?

65862-249 is the product NDC for Alfuzosin Hydrochloride, Alfuzosin hydrochloride 10 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Alfuzosin Hydrochloride?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Alfuzosin Hydrochloride NDC 65862-249 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-249Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0249Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-249-01	65862024901	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-01)Marketed from Aug 30, 2012
65862-249-05	65862024905	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-05)Marketed from Aug 30, 2012
65862-249-30	65862024930	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-30)Marketed from Aug 30, 2012
65862-249-90	65862024990	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-90)Marketed from Aug 30, 2012
65862-249-99	65862024999	1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-249-99)Marketed from Aug 30, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alfuzosin Hydrochloride
Generic name (nonproprietary): alfuzosin hydrochloride
Active ingredients: Alfuzosin hydrochloride — 10 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079060
Marketing start: Aug 30, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 65862-249_ed1ad687-f3a5-465e-915f-9ea4fcf63ed7SPL ID ed1ad687-f3a5-465e-915f-9ea4fcf63ed7SPL set ID d163369b-e44b-4591-b166-7ddd0c1c13c0RxCUI 861132UNII 75046A1XTNUPC 0365862249302
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862024901 followed by a unit qualifier and the quantity

Package 65862-0249-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2026.

Indications (excerpt from the label)

Alfuzosin hydrochloride extended-release tablets are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Alfuzosin hydrochloride extended-release tablets are an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. (1) Important Limitations of Use: Alfuzosin hydrochloride extended-release tablets are not indicated for treatment of hypertension. (1.1) Alfuzosin hydrochloride extended-release tablets are not indicated for use in the pediatric population. (1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use Alfuzosin hydrochloride extended-release tablets are not indicated for the treatment of hypertension.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-249

What is NDC 65862-249?: 65862-249 is the product NDC for Alfuzosin Hydrochloride, Alfuzosin hydrochloride 10 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Alfuzosin Hydrochloride.
What is the active ingredient?: Alfuzosin hydrochloride.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Alfuzosin Hydrochloride?: 14 other product NDCs are listed under this name. See all Alfuzosin Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Alfuzosin Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	84386-153	84386-0153-0184386-0153-0584386-0153-30+2 more
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-2850	60505-2850-09
Alfuzosin hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Northwind Health Company, LLC	51655-967	51655-0967-52
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-087	51655-0087-52
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Northwind Health Company, LLC	51655-432	51655-0432-52
Alfuzosin hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Unichem Pharmaceuticals (USA), Inc.	29300-155	29300-0155-0129300-0155-1329300-0155-19
Alfuzosin hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-9155	63629-9155-0163629-9155-0263629-9155-03+1 more
Alfuzosin hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	43353-945	43353-0945-1643353-0945-3043353-0945-60
Alfuzosin hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Extended releaseOral	Exelan Pharmaceuticals Inc.	76282-302	76282-0302-0176282-0302-0576282-0302-10+2 more
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	57237-114	57237-0114-0157237-0114-0557237-0114-90

All 15 Alfuzosin Hydrochloride NDCs

Other NDCs under ANDA 079060

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079060
Product	Strength	Form · route	Labeler	Product NDC
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-087
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	57237-114
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-2578
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	84386-153